PAPER Nath U, Ben-Shlomo Y, Thomson RG, Morris HR, Wood NW, Lees AJ, Burn DJ11408338
PAPER Bower JH, Maraganore DM, McDonnell SK, Rocca WA
Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990.Neurology. 1997 Nov;49(5):1284-8. PubMed: 9371909
PAPER Apud JA, Mattay V, Chen J, Kolachana BS, Callicott JH, Rasetti R, Alce G, Iudicello JE, Akbar N, Egan MF, Goldberg TE, Weinberger DR17063156
CONFERENCE COVERAGE SERIES Frontotemporal Dementia: The Hard Work of Pushing Toward Trials As research on frontotemporal dementia gathers steam, the international conference hosted its largest gathering ever last month in Munich, Germany. More than 750 researchers shared their ...
PAPER Koscova S, Zakova Slivarichova D, Tomeckova I, Melicherova K, Stelzer M, Janakova A, Kosorinova D, Belay G, Mitrova E
Cerebrospinal Fluid Biomarkers in the Diagnosis of Creutzfeldt-Jakob Disease in Slovak Patients: over 10-Year Period Review.Mol Neurobiol. 2016 Sep 24; PubMed: 27665282
PAPER Sil S, Ghosh T, Gupta P, Ghosh R, Kabir SN, Roy A
Dual Role of Vitamin C on the Neuroinflammation Mediated Neurodegeneration and Memory Impairments in Colchicine Induced Rat Model of Alzheimer Disease.J Mol Neurosci. 2016 Sep 24; PubMed: 27665568
PAPER Antonsdottir IM, Makino KM, Porsteinsson AP27665036
University of UtahSalt Lake City, United States
Rawan Tarawneh on Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease.
COMMENT I'd like to thank Dr. Zetterberg for his comment, and agree with it overall. However, this paper does contain novel information regarding the value of neurogranin as a preclinical biomarker for AD, and its ability to predict future cognitive ...
COMMENT We would like to emphasize that the APP knock-in mice do not display any tau pathology or neurodegeneration. This suggests that Aβ pathology might account, at least in part, for cognitive dysfunction in AD via disturbance of neuronal activities, because ...
No filters selected